{"id":11154,"date":"2018-08-10T08:27:12","date_gmt":"2018-08-10T12:27:12","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11154"},"modified":"2018-08-10T08:27:12","modified_gmt":"2018-08-10T12:27:12","slug":"trump-administration-sinks-teeth-into-paring-down-drug-prices-on-5-key-points","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11154","title":{"rendered":"Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points"},"content":{"rendered":"

(By Sarah Jane Tribble for Kaiser Health News)<\/p>\n

Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.<\/p>\n

Many details have yet to be announced. But experts who pay close attention to federal drug policy and Medicare rules say the administration is preparing to incrementally roll out a multipronged plan that tasks the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration with promoting competition, attacking the complicated drug rebate system and introducing tactics to lower what the government pays for drugs. Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Sarah Jane Tribble for Kaiser Health News) Three months after President Donald Trump announced his blueprint to bring down<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,10,6,15],"tags":[],"class_list":["post-11154","post","type-post","status-publish","format-standard","hentry","category-health-care-redesign","category-legislative-update","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11154"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11154\/revisions"}],"predecessor-version":[{"id":11155,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11154\/revisions\/11155"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}